NCT04640402 A Phase Ⅱ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells) Status COMPLETED Phase PHASE2
NCT04637828 A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection Status UNKNOWN Phase PHASE2
NCT04634409 A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness Status COMPLETED Phase PHASE2
NCT04628143 A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia Status COMPLETED Phase PHASE2
NCT04628039 Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs Status COMPLETED Phase N/A
NCT04625972 Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults Status COMPLETED Phase PHASE3
NCT04625725 Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult. Status COMPLETED Phase PHASE3
NCT04624997 Coagulopathy and Vasculopathy Assessment as a Predictor of the Severity of SARS-CoV-2 / COVID-19 Infection Status UNKNOWN Phase N/A
NCT04623021 A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia Status COMPLETED Phase PHASE2
NCT04622865 Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19 Status UNKNOWN Phase PHASE2
NCT04621149 An Outpatient Study Investigating Non-prescription Treatments for COVID-19 Status TERMINATED Phase PHASE2
NCT04621071 Efficacy of Probiotics in Reducing Duration and Symptoms of COVID-19 Status COMPLETED Phase NA
NCT04619706 Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19 Status TERMINATED Phase PHASE2